Literature DB >> 30025215

MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome.

Angela J Rogers1, Joseph F Solus2, Gary M Hunninghake3, Rebecca M Baron3, Nuala J Meyer4, David R Janz5, David A Schwartz6, Addison K May2, William E Lawson2,7, Timothy S Blackwell2,7, Lorraine B Ware2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30025215      PMCID： PMC6290941          DOI： 10.1164/rccm.201801-0140LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  7 in total

1.  Interstitial Lung Abnormalities Are Associated with Acute Respiratory Distress Syndrome.

Authors:  Rachel K Putman; Gary M Hunninghake; Paul B Dieffenbach; Diana Barragan-Bradford; Karolina Serhan; Ursula Adams; Hiroto Hatabu; Mizuki Nishino; Robert F Padera; Laura E Fredenburgh; Rebecca M Baron; Joshua A Englert
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

2.  Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Fernando J Martinez; Augustine M Choi; Russell P Bowler; Elizabeth A Regan; Jeffrey L Curtis; MeiLan K Han; Richard C Boucher; Wanda K O'Neal; Hiroto Hatabu; David A Lynch; Ivan O Rosas; Gary M Hunninghake; Raul San Jose Estepar; George R Washko
Journal:  Thorax       Date:  2018-02-13       Impact factor: 9.139

3.  A common MUC5B promoter polymorphism and pulmonary fibrosis.

Authors:  Max A Seibold; Anastasia L Wise; Marcy C Speer; Mark P Steele; Kevin K Brown; James E Loyd; Tasha E Fingerlin; Weiming Zhang; Gunnar Gudmundsson; Steve D Groshong; Christopher M Evans; Stavros Garantziotis; Kenneth B Adler; Burton F Dickey; Roland M du Bois; Ivana V Yang; Aretha Herron; Dolly Kervitsky; Janet L Talbert; Cheryl Markin; Joungjoa Park; Anne L Crews; Susan H Slifer; Scott Auerbach; Michelle G Roy; Jia Lin; Corinne E Hennessy; Marvin I Schwarz; David A Schwartz
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

4.  Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.

Authors:  Hollis R O'Neal; Tatsuki Koyama; Elizabeth A S Koehler; Edward Siew; Blake R Curtis; Richard D Fremont; Addison K May; Gordon R Bernard; Lorraine B Ware
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

5.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material.

Authors:  Niall D Ferguson; Eddy Fan; Luigi Camporota; Massimo Antonelli; Antonio Anzueto; Richard Beale; Laurent Brochard; Roy Brower; Andrés Esteban; Luciano Gattinoni; Andrew Rhodes; Arthur S Slutsky; Jean-Louis Vincent; Gordon D Rubenfeld; B Taylor Thompson; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2012-08-25       Impact factor: 17.440

6.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

7.  Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.

Authors:  Lorraine B Ware; Tatsuki Koyama; Zhiguo Zhao; David R Janz; Nancy Wickersham; Gordon R Bernard; Addison K May; Carolyn S Calfee; Michael A Matthay
Journal:  Crit Care       Date:  2013-10-24       Impact factor: 9.097
  7 in total
  3 in total

Review 1.  From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?

Authors:  Jacob E Michalski; Jonathan S Kurche; David A Schwartz
Journal:  Transl Res       Date:  2021-09-20       Impact factor: 10.171

Review 2.  Genomics and the Acute Respiratory Distress Syndrome: Current and Future Directions.

Authors:  Tamara Hernández-Beeftink; Beatriz Guillen-Guio; Jesús Villar; Carlos Flores
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

3.  SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

Authors:  Yixuan J Hou; Kenichi Okuda; Caitlin E Edwards; David R Martinez; Takanori Asakura; Kenneth H Dinnon; Takafumi Kato; Rhianna E Lee; Boyd L Yount; Teresa M Mascenik; Gang Chen; Kenneth N Olivier; Andrew Ghio; Longping V Tse; Sarah R Leist; Lisa E Gralinski; Alexandra Schäfer; Hong Dang; Rodney Gilmore; Satoko Nakano; Ling Sun; M Leslie Fulcher; Alessandra Livraghi-Butrico; Nathan I Nicely; Mark Cameron; Cheryl Cameron; David J Kelvin; Aravinda de Silva; David M Margolis; Alena Markmann; Luther Bartelt; Ross Zumwalt; Fernando J Martinez; Steven P Salvatore; Alain Borczuk; Purushothama R Tata; Vishwaraj Sontake; Adam Kimple; Ilona Jaspers; Wanda K O'Neal; Scott H Randell; Richard C Boucher; Ralph S Baric
Journal:  Cell       Date:  2020-05-27       Impact factor: 41.582
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.